(NYSE: ALC) Alcon's forecast annual revenue growth rate of 5.61% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.54%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.49%.
Alcon's revenue in 2025 is $10,025,000,000.On average, 6 Wall Street analysts forecast ALC's revenue for 2025 to be $5,128,841,328,000, with the lowest ALC revenue forecast at $5,102,504,640,000, and the highest ALC revenue forecast at $5,164,008,000,000. On average, 6 Wall Street analysts forecast ALC's revenue for 2026 to be $5,495,114,107,200, with the lowest ALC revenue forecast at $5,456,940,000,000, and the highest ALC revenue forecast at $5,540,246,400,000.
In 2027, ALC is forecast to generate $5,833,451,308,800 in revenue, with the lowest revenue forecast at $5,806,322,592,000 and the highest revenue forecast at $5,895,720,000,000.